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IN VITRO AND IN VIVO PERFORMANCE OF NANOSIZED HYDROXYAPATITE 
PARTICLES COATED WITH POLY-DL-LACTIDE-CO-GLYCOLIDE AS SYSTEMS 
FOR DRUG DELIVERY OF TIGECYCLINE 
 
N. Ignjatović1, P. Ninkov2, R. Sabetrasekh2, P. Lyngstadaas2, D. Uskoković1 
1Institute of Technical Sciences of SASA, Belgrade, Serbia 
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 Calcium-phosphate/poly(dl-lactide-co-glycolide) (CP/PLGA) composite biomaterial in 
granular form showed a high potential in the reconstruction of bone tissue. Compared to pure 
polymers, the combination of CP with biodegradable polymers used in bone drug delivery 
systems shows certain advantages. Composite biomaterials in nano particulate (NPs) form may 
have significant advantages over those in micro- or submicro-particulate form.  
 The purpose of the study presented in this paper has been to examine the possibility of 
the synthesis of a new nanoparticulate system for controlled and systemic drug delivery with 
double effect. In the first step, a drug is released from bioresorbable polymer; in the second 
stage, after resorption of the polymer, non-bioresorbable calcium phosphate remains the chief 
part of the particle and takes the role of a filler, filling a bone defect. The obtained tigecycline-
loaded calcium-phosphate(CP)/poly(dl-lactide-co-glycolide)(PLGA) nano particles contain 
calcium phosphate coated with bioresorbable polymer and 0.6, 2 and 5wt% tigecycline. 
 The composite was analyzed by FT-IR, XRD, HPLC and AFM methods. The average 
particle size of the nanocomposite increases with the augmentation of the part of antibiotics, and 
it ranges from 65 to 95 nm. Release profiles of tigecycline were obtained by UV-VIS 
spectroscopy in physiological solution at 37oC. Experimental results were analyzed using 
Peppas and Weibull mathematical models. Based on kinetic parameters, tigecycline release was 
defined as non-Fickian transport. The in vitro cytotoxicity of the nanocomposite was examined 
on standard cell lines of MC3T3-E1, in vitro. The obtained low values of LDH activity (under 
37%) indicate low cytotoxicity level. Inhibition of bacteria in aerobic and anaerobic conditions 
in vitro was analyzed after 1, 2 and 3 weeks. The behaviour of the composite under real-life 
conditions was analyzed through implantation of the nanocomposite into living organisms, in 
vivo. The system with the lowest tigecycline content proved to be an adequate system for local 
and controlled release.  
